INSPECTION & LICENSING

 

The Inspection and Licensing section is mainly responsible for compliance and enforcement of the Medicines and Related Substances Control Act, 2003 (Act 13 of 2003). Licensing and Registration of premises have been introduced in reviewing the applications for licences and issuing the licences is the responsibility for this section. Ensuring that all manufacturers in and outside the country who apply for registration of their products in Namibia and those with registered products in Namibia follow the current Good Manufacturing Practices (cGMP) as outlined in the WHO cGMP guidelines is also one of the activities of this section. 

Compliance and Enforcement

The inspectorate is concerned with compliance and enforcement as its core functions. This involves current Good Manufacturing Practices (GMP) inspections to ensure compliance in the following establishments: manufacturing, testing, distribution, wholesaling and importing of medicines.

Good Distribution Practice shall also be complied with;

  • Good Distribution Practice: is a quality system which ensures that medicinal products are stored and handled consistently under appropriate conditions as required by Council on registration as given in the specifications so that the quality of the product will be maintained during storage and distribution.
  • Compliance verification: this involves compliance verification and investigation activities in the area of medicines as defined in the Medicines and Related Substances Control Act, 2003. This involves collection of samples from distribution outlets for examination to ensure that standards are maintained post registration.
  • Enforcement of the law: This involves activities to ensure compliance with the law regarding the sale and use of medicines as provided for in the Act. The activities involve inspection of pharmacies, dispensing medical practitioners, hospitals and all health facilities.
  • Liaising with customs officers: Visiting all border posts to ensure that only registered medicines are imported and that importation is done by licenced manufacturers and wholesalers/distributors Inspection of general retail outlets: This activity is aimed at ensuring that medicines are sold only by authorized persons and in authorized premises.

Licensing and Registration of premises

The inspectorate manages and issues licences as required in the Medicines Control Act, 2003. The Inspectorate Section is responsible for ensuring that:

  • Wholesalers / distributors of medicines have import/export licences. All health practitioners who are not pharmacists and who intend to sell/dispense have a licence for that purpose from NMRC.
  • Pharmacists who prescribe and dispense medicine schedules other than schedule 1 must have a licence for that purpose.
  • All medicine manufacturers are registered with NMRC All foreign manufacturers comply with cGMP before registration of their products with NMRC and that the level of cGMP is maintained by periodic assessment or inspection of the site as the Council may determine.

Requirements

  • The manufacturing of pharmaceuticals requires compliance with cGMP (current Good Manufacturing Practice).
  • All premises where medicines are manufactured must be registered with the NMRC after payment of the prescribed fee.
  • Import/export licences are granted to registered Manufacturers, Wholesalers and Distributors.
  • Licences are issued for a period of one calendar year and are renewable annually during the first month of the year.

Types of licences/permits

  • The manufacturing of pharmaceuticals requires compliance with cGMP.
  • Procedure for obtaining a License for selling/dispensing of medicine.
  • Application shall be made to Council in the prescribed format and accompanied with the prescribed fee.
  • The business premises shall be inspected to ensure they are suitable for the intended purpose. The business premises shall be inspected to ensure they are suitable for the intended purpose.
  • Change of premises Any change of a registered premise must be approved by Council. 

Inspection of Pharmaceutical Operations

The following inspection types shall be undertaken:

  • Spot inspection: The inspections are conducted randomly during the premises operating times. This is to ensure that premises are trading in compliance with specified requirements. Random checks are carried out to ensure that licensed premises are under the continuous personal supervision of registered persons in line with the relevant legal requirements.
  • Routine inspection: The Inspections unit conducts routine inspections for all regulated entities at least once a year. The frequency of inspections can be increased or reduced based on the risk associated with the premises.
  • Investigative inspection: Investigations may be carried out because of non-compliances identified in the inspection process or using intelligence gathered by BoMRA, other agencies or reported by members of the public. Investigation activities are frequently conducted in conjunction with other law enforcement agencies.
  • Pre-licensing inspection: Inspection checks are conducted to assess compliance with the minimum requirements before issuing of license for operating a pharmaceutical business operation.